Alembic Pharmaceuticals Ltd
APLLTD
Company Profile
Business description
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities.
Contact
Alembic Road
VadodaraGJ390 003
INDT: +91 2652280550
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
16,571
Stocks News & Analysis
stocks
Moated ASX player makes moves to support growth in China
a2Milk announced an acquisition and a divestiture as it aims to take a bigger slice of China’s baby formula market.
stocks
Cochlear earnings: Shares overvalued as demand softens
Cochlear’s met expectations, but investors overly optimistic.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,173.80 | 59.70 | -0.65% |
| CAC 40 | 7,979.08 | 95.03 | 1.21% |
| DAX 40 | 24,423.07 | 108.30 | 0.45% |
| Dow JONES (US) | 44,922.27 | 10.45 | 0.02% |
| FTSE 100 | 9,189.22 | 31.48 | 0.34% |
| HKSE | 25,122.90 | 53.95 | -0.21% |
| NASDAQ | 21,314.95 | 314.82 | -1.46% |
| Nikkei 225 | 43,546.29 | 168.02 | -0.38% |
| NZX 50 Index | 12,928.68 | 41.96 | -0.32% |
| S&P 500 | 6,411.37 | 37.78 | -0.59% |
| S&P/ASX 200 | 8,896.20 | 63.10 | -0.70% |
| SSE Composite Index | 3,727.29 | 0.74 | -0.02% |